Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Nu Skin Enterprises, Inc. NUS

Consumer Defensive — Household & Personal Products
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
0.05
Total sells
0.10
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — 1 — — — — — — — — — —
Sell — — — — — — — 1 2 — — —
Insider Ownership
2.79%

Capital & Financial Ratios

Market Cap
223.91
Revenue
1,375.25
Net Income
(216.39)
Free Cash Flow
10.78
Net Debt
22.28
Current Ratio
1.98
Debt/Equity
0.39
P/E ratio
0.00
P/S ratio
0.16
P/B ratio
0.41
Past 5Y EPS Growth
(39.68%)
This Y EPS Growth
(35.43%)
Next Y EPS Growth
41.46%
Next 5Y EPS Growth
(6.46%)
in millions of $

Dividends

Payout Ratio
1.11
Annual Dividend Rate
1.56
Annual Dividend Yield
8.75%
total individual payouts
2026 0.24
—
—
—
2025 0.24
—
—
—
—
2024 0.24
—
—
—
—
2023 1.56
—
—
—
—
2022 1.54
—
—
—
—
2021 1.52
—
—
—
—
2020 1.50
—
—
—
—
2019 1.48
—
—
—
—
2018 1.46
—
—
—
—
2017 1.44
—
—
—
—
2016 1.42
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 267.82 197.99 239.84 191.39
Receivables 58.70 50.78 39.54 48.90
Inventory 279.98 190.24 178.64 191.50
Other 14.32 26.94 — —
701.87 538.60 547.70 508.15
2023 2024 2025 Q'26
Payables 43.11 34.88 26.18 37.71
ST’ Debt 25.00 30.00 20.00 20.00
Other 7.06 13.92 — —
328.87 296.61 263.73 256.35
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 320.61 320.11 — —
—
’25 364.49 386.14 364.21 370.32
1,485.16
’24 417.31 439.08 430.15 445.55
1,732.08
’23 481.46 500.26 498.77 488.64
1,969.13
’22 604.90 560.62 537.81 522.34
2,225.66
’21 677.03 704.06 641.15 673.44
2,695.67
’20 518.03 612.37 703.35 748.19
2,581.93
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (3.92) 10.63 — —
—
’25 0.39 35.80 27.48 16.62
80.29
’24 3.32 51.21 31.43 25.79
111.74
’23 (22.08) 35.52 51.03 54.17
118.64
’22 7.54 46.56 28.44 25.53
108.06
’21 (18.86) 20.72 30.21 109.51
141.58
’20 69.03 97.05 118.37 94.69
379.14
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (17.63) 4.99 — —
—
’25 (13.19) 35.78 17.57 5.86
46.01
’24 (8.96) 43.08 22.84 13.20
70.16
’23 (33.56) 20.81 39.12 33.78
60.15
’22 (2.74) 37.02 2.99 11.74
49.01
’21 (38.23) 3.24 16.68 91.28
72.97
’20 49.64 87.75 98.25 79.68
315.32
in millions of $

EPS

Mar Jun Sep Dec Year
’26 0.04 (5.14) — —
—
’25 2.14 0.43 0.34 0.29
3.18
’24 (0.01) (2.38) 0.17 (0.73)
(2.95)
’23 0.23 0.54 (0.74) 0.15
0.17
’22 0.76 0.67 (0.51) 1.15
2.07
’21 0.91 1.15 0.97 (0.18)
2.86
’20 0.36 0.81 1.08 1.40
3.63

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

3
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 29.96 16.15 5.95 5.32 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 56.76 45.55 20.75 14.62 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,800 3,700 3,100 2,800 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.59 0.53 0.56 0.53 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,225.66 1,969.13 1,732.08 1,485.16 ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 71.65% 68.93% 68.23% 69.45% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 88.97 26.58 (175.05) 196.20 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.00% 1.35% (10.11%) 13.21% ‡‡‡ ‡‡‡ —
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 104.78 8.60 (146.59) 160.20 ‡‡‡‡‡ ‡‡‡‡‡ —
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 72.51 70.92 69.81 52.26 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 44.51 39.61 34.88 30.13 ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 2.10 0.17 (2.95) 3.25 ‡‡‡‡‡ ‡‡‡‡ —
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.16 2.39 2.25 1.63 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.18) (1.18) (0.84) (0.70) ‡‡‡ ‡‡‡ —
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.98 1.21 1.41 0.93 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 17.95 16.53 13.12 16.34 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 50.00 49.71 49.66 49.29 ‡‡‡‡‡ ‡‡‡‡‡ —
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 20.12 112.89 0.00 2.97 ‡‡‡ ‡‡‡‡ —
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.95 0.51 0.20 0.32 ‡‡‡ ‡‡‡ —
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.35 1.23 0.53 0.59 ‡‡‡ ‡‡‡ —
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.00 0.63 0.31 0.31 ‡‡‡‡ ‡‡‡‡ —
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 45.64 20.70 7.67 9.97 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 108.06 118.64 111.74 80.29 ‡‡‡ ‡‡‡ —
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (59.06) (58.49) (41.58) (34.28) — — —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 49.01 60.15 70.16 46.01 — — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 400.63 373.00 241.99 283.96 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 402.47 503.04 393.61 224.19 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 123.96 235.22 195.62 (15.65) — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 897.30 821.97 651.46 805.24 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.62% 0.47% (8.95%) 11.15% — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6.78% 2.85% (11.18%) 5.21% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.58% 1.00% (19.90%) 22.00% — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Nu Skin Enterprises (NUS), a direct-selling leader in anti-aging skincare and wellness products, has endured a dramatic downturn after peaking at $2.7 billion in revenue in 2021, plunging 36% to $1.73 billion by 2024 amid macroeconomic headwinds, post-pandemic shifts away from direct sales, and severe regulatory crackdowns on MLM models—especially in China, its core market contributing 40-50% of sales. Profitability flipped from $147 million in profits to a matching loss, with stock prices cratering from $56 lows in 2018 to $6 in 2024, mirroring sector peers like Herbalife amid eroding margins (down to 68%) and workforce cuts.

Despite income statement woes, balance sheet resilience shines through positive free cash flow ($70 million in 2024), manageable net debt, and deeply discounted valuations (forward P/E 3.4x, P/S 0.20x), positioning NUS as a potential value play. Insider activity shows net selling by directors but buys from the Chief Product Officer, signaling mixed confidence amid litigation risks and China uncertainties.

Analysts forecast a 2025 inflection with revenues stabilizing at $1.50 billion, EPS rebounding to $3.21, and FCF rising 36%, hinging on new launches like RenuSpa, cost efficiencies, and possible U.S. wellness tailwinds—yet persistent MLM stigma and margin pressures cap upside, making it a high-beta bet on direct-selling revival.

Read full commentary →

Nu Skin Enterprises, Inc. (NUS) Latest News

News by impact score

Fine-tune

11 Aug

3 transcript www.marketbeat.com, 12:03 AM
Nu Skin Enterprises Q2 earnings call highlighted financial results, operational updates, and forward guidance for the company. Q2 earnings updates typically influence near-term sentiment and guidance without fundamentally shifting long-term trajectory.

10 Aug

3 , 4:06 PM
Nu Skin Enterprises reported second quarter financial results including revenue, earnings and operational metrics. Quarterly results supply performance data that can shift near-term investor sentiment and valuation.

3 transcript app.moby.co, 8:30 AM
Nu Skin Enterprises held Q2 2026 earnings call covering revenue, profit figures, segment performance, and management outlook on growth initiatives and market conditions. Quarterly earnings call supplies updated financial metrics and guidance that moderately shift near-term investor expectations and valuation models.

18 May

3 Simply Wall St., 8:50 AM
Nu Skin Enterprises reports profits that may mask deeper operational challenges and market pressures likely to weigh on future results and investor confidence. Cautionary tone around reported profits signals possible negative revisions to earnings outlook and near-term stock performance.

13 May

4 www.marketbeat.com, 4:08 AM
Nu Skin Enterprises released Q1 earnings call highlights covering financial results, strategic initiatives, and forward guidance. Q1 earnings highlights detail financial performance and outlook, poised to significantly sway investor sentiment and stock trajectory.

8 May

4 app.moby.co, 8:30 AM
Nu Skin Enterprises, Inc. released Q1 2026 earnings call summary covering financial results, strategic updates, and future outlook. Q1 2026 earnings call summary details financial performance and guidance that significantly affect stock trajectory and investor sentiment.

7 May

4 Business Wire, 4:06 PM
Nu Skin Enterprises reported first quarter results, including revenue, adjusted earnings per share, and guidance for the year. Quarterly earnings reports disclose financial performance and guidance that significantly influence stock price and investor sentiment.

3 Zacks, 7:05 PM
Nu Skin Enterprises (NUS) reported Q1 earnings and revenues below analyst estimates. Q1 earnings and revenue misses directly affect financial performance and short-term market sentiment.

2 Apr

4 Business Wire, 4:25 PM
Nu Skin Enterprises, Inc. (NUS) launches Prysm iO™, a revolutionary AI-powered platform enabling personalized nutritional wellness through advanced health insights and customized recommendations. Prysm iO™ launch introduces cutting-edge AI personalization to Nu Skin's core wellness business, positioning it for substantial growth in competitive health tech markets.

13 Feb

4 transcript app.moby.co, 8:30 AM
Nu Skin Enterprises, Inc. reported its Q4 2025 earnings, highlighting a revenue increase driven by strong sales in its skincare and wellness segments. The company emphasized its commitment to innovation and expanding its global market presence. Management provided guidance for the upcoming quarter, projecting continued growth and investment in new product lines. Challenges in certain markets were acknowledged, but overall performance exceeded analyst expectations, leading to a positive outlook for the next fiscal year. The earnings report indicates significant growth and strategic initiatives that could alter the company's trajectory and investor sentiment.

4 transcript www.marketbeat.com, 1:09 AM
Nu Skin Enterprises reported its Q4 earnings, highlighting a 5% increase in revenue year-over-year, driven by strong sales in its Asia-Pacific region. The company emphasized its commitment to innovation and sustainability, launching new products aimed at enhancing customer engagement. Management expressed optimism about future growth, citing strategic investments and a focus on digital transformation. However, challenges such as regulatory scrutiny and market competition were acknowledged. Overall, the earnings call reflected a positive outlook for the upcoming fiscal year. The reported revenue growth and strategic initiatives indicate significant potential for future performance and market positioning.

4 , 12:03 AM
Nu Skin Enterprises, Inc. reported strong earnings growth in Q4 2025, highlighting significant increases in revenue and profitability. The company attributed this success to effective marketing strategies and product innovations that resonated well with consumers. Additionally, management expressed optimism about future growth prospects, citing ongoing investments in technology and expansion into new markets. Overall, the earnings call reflected a positive outlook for the company's performance moving forward. Strong earnings growth and strategic investments indicate significant potential for future performance and market positioning.

3 Zacks, 10:02 AM
Nu Skin Enterprises, Inc. reported Q4 earnings that fell short of estimates, with revenues declining year-over-year. The company's financial performance reflects ongoing challenges in its market segment, impacting investor sentiment and future outlook. Declining revenues and missed earnings estimates may moderately influence financial performance and market perception.

3 TMX Newsfile, 9:43 AM
Stonegate Capital Partners has updated its coverage on Nu Skin Enterprises, Inc. (NUS) for the fourth quarter of 2025, providing insights into the company's performance and future outlook. The report highlights key financial metrics and strategic initiatives that may influence NUS's market position and investor sentiment moving forward. The coverage update is expected to moderately influence Nu Skin's financial performance and market positioning.

12 Feb

3 ZacksMT NewswiresZacksZacksZacksZacks, 5:55 PM
Nu Skin Enterprises, Inc. (NUS) reported Q4 earnings and revenues that fell short of analysts' estimates, raising concerns about the company's financial performance. The disappointing results may impact investor sentiment and raise questions about future growth prospects. Despite efforts to enhance product offerings and market strategies, the company faces challenges in meeting expectations, which could affect its competitive positioning in the market. Earnings and revenue misses can moderately influence investor sentiment and financial performance.

3 Associated Press Finance, 4:53 PM
Nu Skin Enterprises, Inc. reported its Q4 earnings, highlighting key financial metrics and performance indicators. The company experienced fluctuations in revenue and profit margins, reflecting ongoing challenges in the market. Management provided insights into future strategies and product developments aimed at enhancing growth. Overall, the earnings report indicates a mixed performance with potential areas for improvement. The earnings report reveals moderate fluctuations in financial performance that could influence investor sentiment and operational strategies.

3 Business Wire, 4:06 PM
Nu Skin Enterprises, Inc. (NUS) reported its fourth quarter and full-year 2025 results, which fell within the company's guidance. The financial performance reflects stable operations and adherence to projected targets, indicating a consistent business strategy. Key metrics and insights from the report highlight the company's ongoing efforts to maintain market presence and operational efficiency. The results indicate stable performance but do not suggest significant changes in market dynamics or competitive positioning.

11 Feb

3 Zacks24/7 Wall St.Motley FoolBarchartMotley Fool24/7 Wall St.Motley FoolGOBankingRates, 10:46 AM
Nu Skin Enterprises, Inc. is preparing to report its Q4 earnings, with analysts anticipating insights into the company's financial performance and strategic direction. Investors are particularly focused on sales trends, product innovations, and market dynamics that could influence future growth. The upcoming earnings report is expected to provide clarity on the company's operational adjustments and overall market positioning. The earnings report is likely to affect key areas such as financial performance and market sentiment, but the overall impact is expected to be somewhat limited.

6 Feb

3 Business Wire, 1:56 PM
Dr. Joseph Chang has released an updated edition of his bestselling book, 'The Aging Myth,' which includes 15 additional years of research focused on cellular wellness. The new edition aims to provide insights into aging and wellness, reflecting advancements in the field and Nu Skin's commitment to innovation in health and beauty products. The update to the book may enhance Nu Skin's brand image and product innovation, but its overall impact on the company's trajectory is expected to be limited.

14 Jan

3 TMX Newsfile, 4:41 PM
Stonegate attended the ICR 2026 conference, featuring a fireside chat with Nu Skin Enterprises, Inc. (NUS). The event highlighted key insights and discussions surrounding Nu Skin's strategies and market positioning, showcasing the company's focus on innovation and growth in the beauty and wellness sectors. The conference provided insights that may influence Nu Skin's market positioning and operational strategies, but the overall impact is expected to be limited.

3 Business Wire, 4:05 PM
Nu Skin Enterprises, Inc. (NUS) is set to announce its financial results for the fourth quarter and full year of 2025. The announcement is anticipated to provide insights into the company's performance and strategic direction moving forward. The upcoming financial results may influence investor sentiment and provide insights into the company's operational performance.

9 Jan

3 Business Wire, 7:00 AM
Nu Skin Enterprises, Inc. will present its company strategy and opportunities at the upcoming ICR Conference. The discussion aims to provide insights into the company's future direction and potential growth areas, engaging with investors and stakeholders. The presentation at the ICR Conference may influence investor sentiment and provide insights into future strategies, but its overall impact is expected to be limited.

4 Jan

3 Simply Wall St., 9:12 AM
Nu Skin Enterprises, Inc. (NUS) is facing concerns regarding its returns on capital, which have raised red flags for investors. The company's performance metrics suggest that it may not be effectively utilizing its capital, leading to questions about its long-term sustainability and growth potential. Analysts are urging caution as these indicators could signal deeper issues within the company's operational efficiency and market strategy. Concerns about returns on capital may moderately influence investor sentiment and financial performance.

30 Dec

3 Business Wire, 6:01 PM
Nu Skin Enterprises, Inc. has released its 2024 Social Impact and Sustainability Report, highlighting its commitment to social responsibility and environmental sustainability. The report outlines various initiatives aimed at improving community well-being and reducing the company's environmental footprint. Key focus areas include sustainable sourcing, reducing carbon emissions, and enhancing product transparency. The company aims to engage stakeholders and promote positive change through its sustainability efforts. The report reflects a commitment to sustainability that may enhance brand reputation and customer loyalty, but its immediate financial impact is expected to be limited.

3 Zacks, 10:37 AM
Nu Skin Enterprises, Inc. (NUS) is experiencing challenges in its market performance, particularly in the context of competition and changing consumer preferences. The company is focusing on innovation and expanding its product offerings to regain market share. Analysts are closely monitoring its financial metrics and strategic initiatives to assess future growth potential. Current market challenges and strategic initiatives may moderately influence Nu Skin's financial performance and competitive positioning.

23 Dec

3 ZacksZacks, 11:17 AM
Nu Skin Enterprises, Inc. (NUS) is navigating challenges related to tariff-driven costs, similar to ELF's pricing strategy. The company is exploring ways to offset these costs through strategic pricing adjustments and product offerings. This approach aims to maintain market competitiveness while addressing the financial pressures stemming from tariffs. The effectiveness of these strategies will be crucial for NUS's performance through 2026. Tariff-driven cost adjustments may moderately influence Nu Skin's financial performance and competitive positioning.

18 Dec

4 Business WireZacksSimply Wall St.WWDMT NewswiresWWDZacks, 10:01 AM
Nu Skin Enterprises, Inc. has launched Prysm iO™, a new intelligent nutritional wellness platform designed to enhance personalized health and wellness experiences. This innovative product leverages advanced technology to provide tailored nutritional insights and recommendations, aiming to empower users in their wellness journeys. The launch reflects Nu Skin's commitment to innovation in the health and wellness sector, positioning the company to meet the growing demand for personalized nutrition solutions. The introduction of Prysm iO™ represents a significant strategic move that could enhance Nu Skin's competitive positioning in the nutritional wellness market.

4 ZacksStockStory, 8:40 AM
Nu Skin Enterprises, Inc. (NUS) is highlighted among three beauty and cosmetic stocks poised for sustainable growth due to its innovative product offerings and strong market positioning. The company is leveraging technology and consumer trends to enhance its product lines and expand its customer base, which is expected to drive future revenue growth. Analysts suggest that Nu Skin's focus on sustainability and wellness aligns well with current market demands, positioning it favorably against competitors. Nu Skin's strategic focus on innovation and sustainability is likely to significantly impact its future performance and market positioning.

17 Dec

3 ZacksZacksZacks, 11:13 AM
Nu Skin Enterprises, Inc. (NUS) is exploring brand-led innovation strategies to sustain growth momentum in FY26. The company aims to leverage its brand identity to enhance product offerings and market presence, focusing on consumer engagement and adapting to market trends. This approach is expected to drive sales and strengthen competitive positioning in the beauty and wellness sectors. Brand-led innovation may moderately influence Nu Skin's financial performance and competitive positioning.

14 Dec

4 Simply Wall St., 7:25 AM
Nu Skin Enterprises, Inc. (NYSE:NUS) has a strong institutional backing, with 75% of its ownership held by institutional investors. This significant ownership indicates confidence in the company's stability and growth potential, which may positively influence its market performance and investor sentiment. High institutional ownership typically reflects strong investor confidence and can significantly impact market performance.
© 2016–2026 stockrow.com Terms and Conditions Indicators Weekly Summary Contact Us